Friday, December 25, 2009

Spersadexolina




Spersadexolina may be available in the countries listed below.


Ingredient matches for Spersadexolina



Chloramphenicol

Chloramphenicol is reported as an ingredient of Spersadexolina in the following countries:


  • Colombia

  • Peru

International Drug Name Search

Thursday, December 24, 2009

Ramipril



Pronunciation: RA-mi-pril
Generic Name: Ramipril
Brand Name: Altace

Ramipril may cause injury or death to the fetus if taken after the third month of pregnancy. If you think you may be pregnant, contact your doctor right away.





Ramipril is used for:

Treating high blood pressure or decreasing the risk of heart attack, stroke, and death in certain patients. It may be used alone or with other medicines. It is used along with other medicines to manage heart failure and improve survival after a heart attack. It may also be used for other conditions as determined by your doctor.


Ramipril is an angiotensin-converting enzyme (ACE) inhibitor. It works by relaxing blood vessels. This helps to lower blood pressure.


Do NOT use Ramipril if:


  • you are allergic to any ingredient in Ramipril or to another ACE inhibitor (eg, lisinopril)

  • you have a history of angioedema (swelling of the hands, face, lips, eyes, throat, or tongue; difficulty swallowing or breathing; or hoarseness) caused by treatment with an ACE inhibitor

  • you are in your second or third trimester of pregnancy

  • you are taking telmisartan

Contact your doctor or health care provider right away if any of these apply to you.



Before using Ramipril:


Some medical conditions may interact with Ramipril. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are able to become pregnant

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of heart problems (eg, aortic stenosis, heart failure), blood vessel problems, blood flow problems, bone marrow problems, kidney problems (eg, renal artery stenosis), certain liver problems (eg, ascites, cirrhosis), or diabetes

  • if you have a history of angioedema, a stroke, or a recent heart attack, or you have had a kidney transplant

  • if you have an autoimmune disease (eg, lupus, rheumatoid arthritis, scleroderma)

  • if you are dehydrated or have low blood volume, high blood potassium levels, or low blood sodium levels, or if you are on a low-salt (sodium) diet

  • if you are receiving treatments to reduce sensitivity to bee stings

  • if you are on dialysis or are scheduled to have surgery or undergo anesthesia

Some MEDICINES MAY INTERACT with Ramipril. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Diuretics (eg, furosemide, hydrochlorothiazide) because the risk of low blood pressure may be increased

  • Aldosterone blockers (eg, eplerenone), nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, ibuprofen), potassium-sparing diuretics (eg, spironolactone, triamterene), potassium supplements, or trimethoprim because the risk of high blood potassium levels may be increased

  • Telmisartan because the risk of kidney problems may be increased

  • Certain gold-containing medicines (eg, sodium aurothiomalate) because flushing, nausea, vomiting, and low blood pressure may occur

  • Lithium or thiopurines (eg, azathioprine) because the risk of their side effects may be increased by Ramipril

This may not be a complete list of all interactions that may occur. Ask your health care provider if Ramipril may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Ramipril:


Use Ramipril as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Ramipril by mouth with or without food.

  • Swallow this tablet whole unless your doctor tells you otherwise.

  • Continue to take Ramipril even if you feel well. Do not miss any doses.

  • If you miss a dose of Ramipril, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Ramipril.



Important safety information:


  • Ramipril may cause dizziness, lightheadedness, or fainting. These effects may be worse if you take it with alcohol or certain medicines. Use Ramipril with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Ramipril may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.

  • Ramipril may cause a serious side effect called angioedema. Contact your doctor at once if you develop swelling of the hands, face, lips, eyes, throat, or tongue; difficulty swallowing or breathing; or hoarseness.

  • Ramipril may not work as well in black patients. They may also be at greater risk of side effects. Contact your doctor if your symptoms do not improve or if they become worse.

  • Dehydration, excessive sweating, vomiting, or diarrhea may increase the risk of low blood pressure. Contact your health care provider at once if any of these occur.

  • Rarely, Ramipril may lower the ability of your body to fight infection. This risk may be greater if you have certain other health problems (eg, kidney problems, collagen vascular disease). Avoid contact with people who have colds or infections. Tell your doctor if you notice signs of infection like fever, sore throat, rash, or chills.

  • Check with your doctor before you use a salt substitute or a product that has potassium in it.

  • Tell your doctor or dentist that you take Ramipril before you receive any medical or dental care, emergency care, or surgery.

  • Patients who take medicine for high blood pressure often feel tired or run down for a few weeks after starting treatment. Be sure to take your medicine even if you may not feel "normal." Tell your doctor if you develop any new symptoms.

  • If you have high blood pressure, do not use nonprescription products that contain stimulants. These products may include diet pills or cold medicines. Contact your doctor if you have any questions or concerns.

  • Diabetes patients - Ramipril may affect your blood sugar. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine.

  • Lab tests, including blood pressure, blood electrolyte levels, heart function, or kidney or liver function, may be performed while you use Ramipril. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Use Ramipril with caution in the ELDERLY; they may be more sensitive to its effects.

  • Ramipril should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY AND BREAST-FEEDING: Ramipril may cause birth defects or fetal death if you take it while you are pregnant. If you think you may be pregnant, contact your doctor right away. It is not known if Ramipril is found in breast milk. Do not breast-feed while taking Ramipril.


Possible side effects of Ramipril:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Cough; dizziness; headache; tiredness.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the hands, eyes, mouth, face, lips, throat, or tongue; hoarseness); chest pain; dark urine; decreased urination; difficulty swallowing; infection (eg, fever, chills, persistent sore throat); irregular heartbeat; loss of appetite; pale stools; red, swollen, blistered, or peeling skin; seizures; stomach pain (with or without nausea or vomiting); symptoms of low blood pressure (eg, fainting, severe dizziness, lightheadedness); yellowing of the skin or eyes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Ramipril side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include fainting; severe dizziness or lightheadedness; weakness.


Proper storage of Ramipril:

Store Ramipril between 68 and 77 degrees F (20 and 25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Ramipril out of the reach of children and away from pets.


General information:


  • If you have any questions about Ramipril, please talk with your doctor, pharmacist, or other health care provider.

  • Ramipril is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Ramipril. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Ramipril resources


  • Ramipril Side Effects (in more detail)
  • Ramipril Dosage
  • Ramipril Use in Pregnancy & Breastfeeding
  • Drug Images
  • Ramipril Drug Interactions
  • Ramipril Support Group
  • 12 Reviews for Ramipril - Add your own review/rating


  • Ramipril Prescribing Information (FDA)

  • Ramipril Professional Patient Advice (Wolters Kluwer)

  • Ramipril Monograph (AHFS DI)

  • ramipril Advanced Consumer (Micromedex) - Includes Dosage Information

  • Altace Prescribing Information (FDA)

  • Altace Consumer Overview



Compare Ramipril with other medications


  • Diabetic Kidney Disease
  • Heart Attack
  • Heart Failure
  • High Blood Pressure
  • Left Ventricular Dysfunction

Diconten




Diconten may be available in the countries listed below.


Ingredient matches for Diconten



Flupentixol

Flupentixol is reported as an ingredient of Diconten in the following countries:


  • Bangladesh

Melitracen

Melitracen is reported as an ingredient of Diconten in the following countries:


  • Bangladesh

International Drug Name Search

Friday, December 18, 2009

Toradiur




Toradiur may be available in the countries listed below.


Ingredient matches for Toradiur



Torasemide

Torasemide is reported as an ingredient of Toradiur in the following countries:


  • Italy

International Drug Name Search

Saturday, December 12, 2009

Promycine




Promycine may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Promycine



Colistin Sulfate

Colistin sulfate (a derivative of Colistin) is reported as an ingredient of Promycine in the following countries:


  • Belgium

International Drug Name Search

Thursday, December 10, 2009

Veteusan




Veteusan may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Veteusan



Crotamiton

Crotamiton is reported as an ingredient of Veteusan in the following countries:


  • Austria

International Drug Name Search

Tuesday, December 8, 2009

Humulin 30 / 70




Humulin 30/70 may be available in the countries listed below.


Ingredient matches for Humulin 30/70



Insulin Injection, Biphasic Isophane

Insulin Injection, Biphasic Isophane human (a derivative of Insulin Injection, Biphasic Isophane) is reported as an ingredient of Humulin 30/70 in the following countries:


  • Australia

  • Canada

  • Lithuania

  • Luxembourg

  • Malaysia

  • Poland

  • Singapore

  • Slovakia

International Drug Name Search

Monday, December 7, 2009

Wart-Off




Ingredient matches for Wart-Off



Salicylic Acid

Salicylic Acid is reported as an ingredient of Wart-Off in the following countries:


  • United States

International Drug Name Search

Saturday, December 5, 2009

Carbo activatus




Carbo activatus may be available in the countries listed below.


Ingredient matches for Carbo activatus



Charcoal

Charcoal, Activated is reported as an ingredient of Carbo activatus in the following countries:


  • Hungary

  • Latvia

International Drug Name Search

Thursday, December 3, 2009

Artrozan




Artrozan may be available in the countries listed below.


Ingredient matches for Artrozan



Meloxicam

Meloxicam is reported as an ingredient of Artrozan in the following countries:


  • Russian Federation

International Drug Name Search

Wednesday, December 2, 2009

Acido Clodronico Sandoz




Acido Clodronico Sandoz may be available in the countries listed below.


Ingredient matches for Acido Clodronico Sandoz



Clodronic Acid

Clodronic Acid disodium tetrahydrate (a derivative of Clodronic Acid) is reported as an ingredient of Acido Clodronico Sandoz in the following countries:


  • Italy

International Drug Name Search

Tuesday, November 17, 2009

Prilenor




Prilenor may be available in the countries listed below.


Ingredient matches for Prilenor



Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Prilenor in the following countries:


  • Italy

International Drug Name Search

Monday, November 16, 2009

Clorexidine




Clorexidine may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Clorexidine



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Clorexidine in the following countries:


  • Italy

International Drug Name Search

Sunday, November 15, 2009

Acyrax




Acyrax may be available in the countries listed below.


Ingredient matches for Acyrax



Acyclovir

Aciclovir is reported as an ingredient of Acyrax in the following countries:


  • Finland

Aciclovir sodium salt (a derivative of Aciclovir) is reported as an ingredient of Acyrax in the following countries:


  • Finland

International Drug Name Search

Thursday, November 12, 2009

Captoprilan




Captoprilan may be available in the countries listed below.


Ingredient matches for Captoprilan



Captopril

Captopril is reported as an ingredient of Captoprilan in the following countries:


  • Dominican Republic

International Drug Name Search

Sunday, November 8, 2009

Ditec




Ditec may be available in the countries listed below.


Ingredient matches for Ditec



Cromoglicic Acid

Cromoglicic Acid disodium salt (a derivative of Cromoglicic Acid) is reported as an ingredient of Ditec in the following countries:


  • Slovakia

Fenoterol

Fenoterol hydrobromide (a derivative of Fenoterol) is reported as an ingredient of Ditec in the following countries:


  • Slovakia

Torasemide

Torasemide is reported as an ingredient of Ditec in the following countries:


  • Bangladesh

International Drug Name Search

Saturday, November 7, 2009

Vetalgina




Vetalgina may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vetalgina



Metamizole

Metamizole is reported as an ingredient of Vetalgina in the following countries:


  • Portugal

International Drug Name Search

Friday, November 6, 2009

Brompheniramine/Codeine Syrup


Pronunciation: BROME-fen-IR-a-meen/KOE-deen
Generic Name: Brompheniramine/Codeine
Brand Name: Nalex AC


Brompheniramine/Codeine Syrup is used for:

Relieving runny nose, sneezing, and cough due to colds, upper respiratory infections, and allergies. It may also be used for other conditions as determined by your doctor.


Brompheniramine/Codeine Syrup is an antihistamine and narcotic cough suppressant combination. The antihistamine works by blocking the action of histamine, which helps reduce symptoms, such as watery eyes and sneezing. The cough suppressant works in the brain to help decrease the cough reflex, which reduces a dry cough.


Do NOT use Brompheniramine/Codeine Syrup if:


  • you are allergic to any ingredient in Brompheniramine/Codeine Syrup or any other codeine- or morphine-related medicine

  • you have severe high blood pressure, severe heart blood vessel disease, angle-closure glaucoma, or peptic ulcers

  • you are unable to urinate or are having an asthma attack

  • you are taking sodium oxybate (GHB) or if you have taken furazolidone or a monoamine oxidase inhibitor (MAOI) (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.



Before using Brompheniramine/Codeine Syrup:


Some medical conditions may interact with Brompheniramine/Codeine Syrup. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have heart blood vessel problems, irregular heartbeat, or any other heart problems (eg, cor pulmonale)

  • if you have a history of high blood pressure; diabetes; liver or kidney problems; stroke; glaucoma or increased pressure in the eye; a blockage of your bladder, stomach, or bowels; ulcers; trouble urinating; an enlarged prostate or other prostate problems; or thyroid problems

  • if you have a history of asthma, chronic cough, lung or breathing problems (eg, chronic bronchitis, emphysema, sleep apnea, slow or irregular breathing), or chronic obstructive pulmonary disease (COPD), or if your cough occurs with large amounts of mucus

  • if you have severe drowsiness, recent head or brain injury, brain tumor, increased pressure in the brain, infection of the brain or nervous system, or a seizure disorder (eg, epilepsy)

  • if you have very poor health or a history of constipation, stomach problems (eg, ulcers), bowel problems (eg, chronic inflammation or ulceration of the bowel), or gallbladder problems (eg, gallstones), or if you have had recent stomach, bowel, or urinary surgery

  • if you have a history of alcohol or substance abuse or suicidal thoughts or behavior

  • if you are taking medicine for high blood pressure or depression

Some MEDICINES MAY INTERACT with Brompheniramine/Codeine Syrup. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Anticholinergics (eg, scopolamine) because serious bowel motility problem (paralytic ileus) may occur

  • Cimetidine, furazolidone, HIV protease inhibitors (eg, ritonavir), MAOIs (eg, phenelzine), sodium oxybate (GHB), or tricyclic antidepressants (eg, amitriptyline) because they may increase the risk of Brompheniramine/Codeine Syrup's side effects

  • Narcotic pain medicines (eg, hydrocodone) because the risk of their side effects may be increased by Brompheniramine/Codeine Syrup

  • Naltrexone, quinidine, or rifamycins (eg, rifampin) because they may decrease Brompheniramine/Codeine Syrup's effectiveness

This may not be a complete list of all interactions that may occur. Ask your health care provider if Brompheniramine/Codeine Syrup may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Brompheniramine/Codeine Syrup:


Use Brompheniramine/Codeine Syrup as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Brompheniramine/Codeine Syrup by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.

  • Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.

  • If you miss a dose of Brompheniramine/Codeine Syrup, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Brompheniramine/Codeine Syrup.



Important safety information:


  • Brompheniramine/Codeine Syrup may cause dizziness, drowsiness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Brompheniramine/Codeine Syrup with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Brompheniramine/Codeine Syrup; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Brompheniramine/Codeine Syrup may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.

  • Brompheniramine/Codeine Syrup has brompheniramine in it. Before you start any new medicine, check the label to see if it has brompheniramine in it too. If it does or if you are not sure, check with your doctor or pharmacist.

  • Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.

  • If your cough or other symptoms persist for more than 1 week, come back, or if you also have fever, rash, or persistent headache, check with your doctor.

  • Brompheniramine/Codeine Syrup may interfere with skin allergy tests. If you are scheduled for a skin test, talk to your doctor. You may need to stop taking Brompheniramine/Codeine Syrup for a few days before the tests.

  • Brompheniramine/Codeine Syrup may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Brompheniramine/Codeine Syrup. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.

  • Tell your doctor or dentist that you take Brompheniramine/Codeine Syrup before you receive any medical or dental care, emergency care, or surgery.

  • Use Brompheniramine/Codeine Syrup with caution in the ELDERLY; they may be more sensitive to its effects, especially confusion, dizziness, drowsiness, dry mouth, excitability, low blood pressure, and trouble urinating.

  • Caution is advised when using Brompheniramine/Codeine Syrup in CHILDREN; they may be more sensitive to its effects, especially excitability.

  • Brompheniramine/Codeine Syrup should not be used in CHILDREN younger than 6 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Brompheniramine/Codeine Syrup while you are pregnant. Do not take Brompheniramine/Codeine Syrup if you are in the third trimester of pregnancy. It is not known if Brompheniramine/Codeine Syrup is found in breast milk. Do not breast-feed while taking Brompheniramine/Codeine Syrup.

When used for long periods of time or at high doses, Brompheniramine/Codeine Syrup may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if Brompheniramine/Codeine Syrup stops working well. Do not take more than prescribed.


When used for long periods of time or at high doses, some people develop a need to continue taking Brompheniramine/Codeine Syrup. This is known as DEPENDENCE or addiction.


If you suddenly stop taking Brompheniramine/Codeine Syrup, you may experience WITHDRAWAL symptoms including anxiety; diarrhea; fever, runny nose, or sneezing; goose bumps and abnormal skin sensations; nausea; vomiting; pain; rigid muscles; rapid heartbeat; seeing, hearing or feeling things that are not there; shivering or tremors; sweating; trouble sleeping.



Possible side effects of Brompheniramine/Codeine Syrup:


All medicines may cause side effects, but many people have no, or minor side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; diarrhea; dizziness; drowsiness; dry mouth, nose, or throat; excitability; headache; loss of appetite; nausea; thickening of mucus secretions; upset stomach; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); blurred vision, double vision, or other vision changes; confusion; difficulty urinating or inability to urinate; fast, slow, or irregular heartbeat; loss of coordination; mood or mental changes; nervousness; ringing in the ears; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; shallow breathing; tremor; trouble sleeping; uncontrolled muscle movements; unusual bruising or bleeding; unusual weakness or tiredness.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Brompheniramine/Codeine side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; shallow breathing; unusually fast, slow, or irregular heartbeat; vomiting.


Proper storage of Brompheniramine/Codeine Syrup:

Store Brompheniramine/Codeine Syrup at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Brompheniramine/Codeine Syrup out of the reach of children and away from pets.


General information:


  • If you have any questions about Brompheniramine/Codeine Syrup, please talk with your doctor, pharmacist, or other health care provider.

  • Brompheniramine/Codeine Syrup is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Brompheniramine/Codeine Syrup. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Brompheniramine/Codeine resources


  • Brompheniramine/Codeine Side Effects (in more detail)
  • Brompheniramine/Codeine Use in Pregnancy & Breastfeeding
  • Brompheniramine/Codeine Drug Interactions
  • Brompheniramine/Codeine Support Group
  • 0 Reviews for Brompheniramine/Codeine - Add your own review/rating


Compare Brompheniramine/Codeine with other medications


  • Cold Symptoms
  • Cough
  • Rhinorrhea

Friday, October 23, 2009

Velkaderm




Velkaderm may be available in the countries listed below.


Ingredient matches for Velkaderm



Clindamycin

Clindamycin dihydrogen phosphate (a derivative of Clindamycin) is reported as an ingredient of Velkaderm in the following countries:


  • Greece

International Drug Name Search

Saturday, October 17, 2009

Uromykol




Uromykol may be available in the countries listed below.


Ingredient matches for Uromykol



Clotrimazole

Clotrimazole is reported as an ingredient of Uromykol in the following countries:


  • Germany

International Drug Name Search

Orphenadrine




In the US, Orphenadrine (orphenadrine systemic) is a member of the drug class skeletal muscle relaxants and is used to treat Migraine and Muscle Spasm.

US matches:

  • Orphenadrine

  • Orphenadrine Extended-Release Tablets

  • Orphenadrine/Aspirin/Caffeine

  • Orphenadrine w/A.C.

  • Orphenadrine Injection

  • Orphenadrine, aspirin, and caffeine

  • Orphenadrine Citrate

  • Orphenadrine Aspirin Caffeine

  • Orphenadrine Extended Release Tablets

  • Orphenadrine Citrate/Aspirin/Caffeine

UK matches:

  • Orphenadrine Hydrochloride 50mg/5ml Oral Solution
  • Orphenadrine Hydrochloride 50mg/5ml Oral Solution (SPC)

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0000083-98-7

Chemical Formula

C18-H23-N-O

Molecular Weight

269

Therapeutic Category

Treatment of Parkinson's disease: Central anticholinergic

Chemical Name

Ethanamine, N,N-dimethyl-2-[(2-methylphenyl)phenylmethoxy]-

Foreign Names

  • Orphenadrinum (Latin)
  • Orphenadrin (German)
  • Orphénadrine (French)
  • Orfenadrina (Spanish)

Generic Names

  • Orfenadrina (OS: DCIT)
  • Orphenadrine (OS: BAN)
  • Orphénadrine (OS: DCF)
  • Orphenadrine Citrate (OS: BANM, USAN)
  • Orphenadrine citrate (PH: BP 2007, USP 32, Ph. Eur. 6)
  • Orphenadrine Citrate (PH: BP 2010)
  • Orphenadrini citras (PH: Ph. Eur. 6)
  • Orphenadrine Hydrochloride (OS: BANM)
  • Orphenadrine Hydrochloride (PH: BP 2010, Ph. Eur. 6)
  • Orphenadrini hydrochloridum (PH: Ph. Eur. 6)

Brand Names

  • Doloctaprin
    Medco, Peru


  • Flamamed
    Perumed, Peru


  • Flexen
    Evex, Peru


  • Mialgin
    Cipa, Peru


  • Norgesic (Orphenadrine and Paracetamol)
    Meda Pharm, Greece


  • Orfenadrina
    Carrion, Peru; LCG, Peru


  • Orphenadrine Citrate Synco
    Synco, Hong Kong


  • Besemax (Orphenadrine and Paracetamol)
    Adcock Ingram Pharmaceuticals, South Africa


  • Besenol (Orphenadrine and Paracetamol)
    Adcock Ingram Pharmaceuticals, South Africa


  • Dolan (Orphenadrine and Paracetamol)
    Leiras, Finland


  • Drinexin
    Farmedic, Peru


  • Efaflex
    Farmaceutica Latina, Peru


  • Efagesic (Orphenadrine and Paracetamol)
    Farmaceutica Latina, Peru


  • Flexin
    Taro, Israel


  • Muscadol (Orphenadrine and Paracetamol)
    Julphar, Oman


  • Myogesic (Orphenadrine and Paracetamol)
    Dar-Al-Dawa, Oman


  • Neodolpasse (Orphenadrine and Diclofenac)
    Fresenius, Slovakia; Fresenius Kabi, Croatia (Hrvatska)


  • Norflex CO (Orphenadrine and Paracetamol)
    iNova Pharmaceuticals, South Africa


  • Norflex
    3M, Costa Rica; 3M, Dominican Republic; 3M, Finland; 3M, Guatemala; 3M, Honduras; 3M, Kenya; 3M, Luxembourg; 3M, Malta; 3M, Panama; 3M, El Salvador; 3M, United States; 3M, Zimbabwe; Douglas, New Zealand; Farmindustria, Peru; Graceway, United States; Graceway Pharmaceuticals, Canada; iNova Pharmaceuticals, Australia; iNova Pharmaceuticals, South Africa; Meda, Germany; Meda, Sweden; Meda Pharm, Greece; Zuoz, Venezuela


  • Norgesic (Orphenadrine and Paracetamol)
    iNova, Singapore; iNova Pharmaceuticals, Australia; Meda, Austria; Meda, Sweden


  • Norphen (Orphenadrine and Paracetamol)
    Atlantic, Singapore


  • Orfenace
    SteriMax, Canada


  • Orfenadrina Citrato MF
    Marfan, Peru


  • Orfenaflex
    Paill, El Salvador


  • Orphenadol (Orphenadrine and Paracetamol)
    Yung Shin, Singapore


  • Orphenadrine Citrate
    Akorn, United States; Bedford, United States; Gavis Pharmaceuticals, United States; Global, United States; Kiel, United States; Sandoz, United States; Watson, United States


  • Plenactol
    3M, Chile


  • Relaflex
    Vijosa, Guatemala; Vijosa, Honduras; Vijosa, Nicaragua; Vijosa, El Salvador


  • Sandoz Orphenadrine
    Sandoz, Canada


  • Biorphen
    Alliance, United Kingdom


  • Disipal
    Astellas, United Kingdom; Astellas, Italy; CSL Biotherapies, New Zealand; png Gerolymatos, Greece; Teva, Israel; Yamanouchi, Luxembourg


  • Lysantin
    Medic, Denmark


  • Orfenadrine HCl CF
    Centrafarm, Netherlands


  • Orfenal
    Remedica, Cyprus; Remedica, Malta


  • Orphenadrine Hydrochloride
    Impax, United States; Rosemont, United Kingdom


  • Orphipal
    GlaxoSmithKline, India

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
SPC Summary of Product Characteristics (UK)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, October 16, 2009

Proinfark




Proinfark may be available in the countries listed below.


Ingredient matches for Proinfark



Dopamine

Dopamine hydrochloride (a derivative of Dopamine) is reported as an ingredient of Proinfark in the following countries:


  • Indonesia

International Drug Name Search

Tuesday, October 13, 2009

Phoenix Xylazine




Phoenix Xylazine may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Phoenix Xylazine



Xylazine

Xylazine is reported as an ingredient of Phoenix Xylazine in the following countries:


  • New Zealand

International Drug Name Search

Monday, October 12, 2009

Epirazole




Epirazole may be available in the countries listed below.


Ingredient matches for Epirazole



Omeprazole

Omeprazole is reported as an ingredient of Epirazole in the following countries:


  • Bahrain

  • Iraq

  • Jordan

  • Kuwait

  • Lebanon

  • Libya

  • Oman

  • Qatar

  • Romania

  • Saudi Arabia

  • Sudan

  • United Arab Emirates

  • Yemen

International Drug Name Search

Friday, October 9, 2009

Tekilon




Tekilon may be available in the countries listed below.


Ingredient matches for Tekilon



Anetholtrithion

Anetholtrithion is reported as an ingredient of Tekilon in the following countries:


  • Taiwan

International Drug Name Search

Wednesday, October 7, 2009

Steripet




Steripet may be available in the countries listed below.


Ingredient matches for Steripet



Fludeoxyglucose (18F)

Fludeoxyglucose (18F) is reported as an ingredient of Steripet in the following countries:


  • Spain

International Drug Name Search

Duro-Tuss Dry Cough




Duro Tuss Dry Cough may be available in the countries listed below.


Ingredient matches for Duro Tuss Dry Cough



Cetylpyridinium

Cetylpyridinium chloride (a derivative of Cetylpyridinium) is reported as an ingredient of Duro Tuss Dry Cough in the following countries:


  • Singapore

Pholcodine

Pholcodine is reported as an ingredient of Duro Tuss Dry Cough in the following countries:


  • New Zealand

  • Singapore

Pseudoephedrine

Pseudoephedrine hydrochloride (a derivative of Pseudoephedrine) is reported as an ingredient of Duro Tuss Dry Cough in the following countries:


  • New Zealand

International Drug Name Search

Wednesday, September 30, 2009

Premique




Premique may be available in the countries listed below.


UK matches:

  • Premique 0.625mg/5mg Coated Tablets
  • Premique Cycle 0.625mg/10mg Coated Tablets
  • Premique Low Dose 0.3mg/1.5mg Modified Release Tablets
  • Premique 0.625mg/5mg Coated Tablets. (SPC)
  • Premique Cycle 0.625mg/10mg Coated Tablets (SPC)
  • Premique Low Dose 0.3mg/1.5mg Modified Release Tablets (SPC)

Ingredient matches for Premique



Conjugated Estrogens

Estrogens, conjugated is reported as an ingredient of Premique in the following countries:


  • Malta

  • United Kingdom

Medroxyprogesterone

Medroxyprogesterone 17α-acetate (a derivative of Medroxyprogesterone) is reported as an ingredient of Premique in the following countries:


  • Malta

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, September 25, 2009

Carcopa




Carcopa may be available in the countries listed below.


Ingredient matches for Carcopa



Carbidopa

Carbidopa is reported as an ingredient of Carcopa in the following countries:


  • Japan

Levodopa

Levodopa is reported as an ingredient of Carcopa in the following countries:


  • Japan

International Drug Name Search

Thursday, September 24, 2009

Taclonex


See also: Generic Taclonex Scalp


Taclonex is a brand name of betamethasone/calcipotriene topical, approved by the FDA in the following formulation(s):


TACLONEX (betamethasone dipropionate; calcipotriene hydrate - ointment; topical)



  • Manufacturer: LEO PHARM

    Approval date: January 9, 2006

    Strength(s): 0.064%;0.005% [RLD]

Has a generic version of Taclonex been approved?


No. There is currently no therapeutically equivalent version of Taclonex available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Taclonex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Crystalline form of a vitamin D analogue
    Patent 5,763,426
    Issued: June 9, 1998
    Inventor(s): Hansen; Erik Torngaard & Rastrup Andersen; Niels Smidt & Ringborg; Lene Hoffmeyer
    Assignee(s): Leo Pharmaceutical Products Ltd.
    The present invention relates to calcipotriol hydrate--a new crystalline form of calcipotriol--with superior technical properties and with superior stability.
    Patent expiration dates:

    • June 9, 2015
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Pharmaceutical composition
    Patent 6,753,013
    Issued: June 22, 2004
    Inventor(s): Erik; Didriksen & Gert; Høy
    Assignee(s): Leo Pharmaceutical Products, Ltd. A/S
    A pharmaceutical composition for dermal use, wherein the composition has a first pharmacologically active component A consisting of at least one vitamin D or vitamin D analogue, and a second pharmacologically active component B consisting of at least one corticosteroid, wherein the difference between the maximum stability pH of said first component A and the maximum stability pH of said second component B is at least 1. The composition can also have at least one solvent component C, where component C is compounds of the general formula R3 (OCH2C(R1)H)xOR2 (I), wherein x is in the range of 2-60, R1 in each of the x units independently is H or CH3, R2 is straight chain or branched C1-20alkyl or benzoyl, and R3 is H or phenylcarbonyloxy; di-(straight or branched)-C4-10alkyl esters of C4-C8dicarboxylic acids; straight or branched C12-18-alkyl benzoates; straight or branched C2-4-alkyl esters of straight or branched C10-18-alkanoic or -alkenoic acids; propylenglycol diesters with C8-14-alkanoic acids; and branched primary C18-24alkanols.
    Patent expiration dates:

    • January 27, 2020
      ✓ 
      Patent use: PSORIASIS
      ✓ 
      Drug product


    • January 27, 2020
      ✓ 
      Patent use: TREATMENT OF MODERATE PLAQUE PSORIASIS
      ✓ 
      Drug product




  • Crystalline form of a vitamin D analogue
    Patent RE39706
    Issued: June 26, 2007
    Inventor(s): Hansen; Erik Torngaard & Andersen; Niels Smidt Rastrup & Ringborg; Lene Hoffmeyer
    Assignee(s): Leo Pharma A/S
    The present invention relates to calcipotriol hydrate—a new crystalline form of calcipotriol—with superior technical properties and with superior stability.
    Patent expiration dates:

    • June 9, 2015
      ✓ 
      Drug substance
      ✓ 
      Drug product



See also...

  • Taclonex Consumer Information (Drugs.com)
  • Taclonex Ointment Consumer Information (Wolters Kluwer)
  • Taclonex topical Consumer Information (Cerner Multum)
  • Taclonex Advanced Consumer Information (Micromedex)
  • Betamethasone/Calcipotriene Ointment Consumer Information (Wolters Kluwer)
  • Betamethasone/Calcipotriene Suspension Consumer Information (Wolters Kluwer)
  • Betamethasone and calcipotriene topical Consumer Information (Cerner Multum)
  • Betamethasone and calcipotriene Topical application Advanced Consumer Information (Micromedex)

Saturday, September 19, 2009

Stomédine




Stomédine may be available in the countries listed below.


Ingredient matches for Stomédine



Cimetidine

Cimetidine is reported as an ingredient of Stomédine in the following countries:


  • France

International Drug Name Search

Mirtazapine Mylan




Mirtazapine Mylan may be available in the countries listed below.


Ingredient matches for Mirtazapine Mylan



Mirtazapine

Mirtazapine is reported as an ingredient of Mirtazapine Mylan in the following countries:


  • Belgium

  • France

International Drug Name Search

Friday, September 18, 2009

Metkar




Metkar may be available in the countries listed below.


Ingredient matches for Metkar



Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Metkar in the following countries:


  • Germany

International Drug Name Search

Methylfenidaathydrochloride PCH




Methylfenidaathydrochloride PCH may be available in the countries listed below.


Ingredient matches for Methylfenidaathydrochloride PCH



Methylphenidate

Methylphenidate hydrochloride (a derivative of Methylphenidate) is reported as an ingredient of Methylfenidaathydrochloride PCH in the following countries:


  • Netherlands

International Drug Name Search

Sunday, September 13, 2009

Buflox




Buflox may be available in the countries listed below.


Ingredient matches for Buflox



Buflomedil

Buflomedil hydrochloride (a derivative of Buflomedil) is reported as an ingredient of Buflox in the following countries:


  • Poland

International Drug Name Search

Friday, September 11, 2009

Ryth




Ryth may be available in the countries listed below.


Ingredient matches for Ryth



Roxithromycin

Roxithromycin is reported as an ingredient of Ryth in the following countries:


  • Bangladesh

International Drug Name Search

Thursday, September 10, 2009

Dispeptal




Dispeptal may be available in the countries listed below.


Ingredient matches for Dispeptal



Pancreatin

Pancreatin is reported as an ingredient of Dispeptal in the following countries:


  • India

International Drug Name Search

Warfarin Norton




Warfarin Norton may be available in the countries listed below.


Ingredient matches for Warfarin Norton



Warfarin

Warfarin sodium salt (a derivative of Warfarin) is reported as an ingredient of Warfarin Norton in the following countries:


  • Hong Kong

International Drug Name Search

Wednesday, September 9, 2009

Teprix




Teprix may be available in the countries listed below.


Ingredient matches for Teprix



Ibuprofen

Ibuprofen is reported as an ingredient of Teprix in the following countries:


  • Argentina

International Drug Name Search

Monday, September 7, 2009

Enabeta




Enabeta may be available in the countries listed below.


Ingredient matches for Enabeta



Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enabeta in the following countries:


  • Germany

International Drug Name Search

Calcitugg




Calcitugg may be available in the countries listed below.


Ingredient matches for Calcitugg



Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Calcitugg in the following countries:


  • Sweden

International Drug Name Search

Profamid




Profamid may be available in the countries listed below.


Ingredient matches for Profamid



Flutamide

Flutamide is reported as an ingredient of Profamid in the following countries:


  • Denmark

  • Finland

  • Latvia

International Drug Name Search

Tuesday, August 25, 2009

Phloroglucinol Qualimed




Phloroglucinol Qualimed may be available in the countries listed below.


Ingredient matches for Phloroglucinol Qualimed



Phloroglucinol

Phloroglucinol is reported as an ingredient of Phloroglucinol Qualimed in the following countries:


  • France

International Drug Name Search

Monday, August 24, 2009

Pantoprazol G.L.




Pantoprazol G.L. may be available in the countries listed below.


Ingredient matches for Pantoprazol G.L.



Pantoprazole

Pantoprazole is reported as an ingredient of Pantoprazol G.L. in the following countries:


  • Austria

International Drug Name Search

Saturday, August 22, 2009

Fluvean




Fluvean may be available in the countries listed below.


Ingredient matches for Fluvean



Fluocinolone

Fluocinolone Acetonide is reported as an ingredient of Fluvean in the following countries:


  • Japan

International Drug Name Search

Pantoprazol AbZ




Pantoprazol AbZ may be available in the countries listed below.


Ingredient matches for Pantoprazol AbZ



Pantoprazole

Pantoprazole sodium (a derivative of Pantoprazole) is reported as an ingredient of Pantoprazol AbZ in the following countries:


  • Germany

International Drug Name Search

Thursday, August 13, 2009

Lisinopril / Hydroklortiazid Actavis




Lisinopril/Hydroklortiazid Actavis may be available in the countries listed below.


Ingredient matches for Lisinopril/Hydroklortiazid Actavis



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Lisinopril/Hydroklortiazid Actavis in the following countries:


  • Sweden

Lisinopril

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisinopril/Hydroklortiazid Actavis in the following countries:


  • Sweden

International Drug Name Search

Tuesday, August 11, 2009

Oracyn-K




Oracyn-K may be available in the countries listed below.


Ingredient matches for Oracyn-K



Phenoxymethylpenicillin

Phenoxymethylpenicillin potassium (a derivative of Phenoxymethylpenicillin) is reported as an ingredient of Oracyn-K in the following countries:


  • Bangladesh

International Drug Name Search

Bonacal




Bonacal may be available in the countries listed below.


Ingredient matches for Bonacal



Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Bonacal in the following countries:


  • Bangladesh

International Drug Name Search

Monday, August 10, 2009

Ocuson




Ocuson may be available in the countries listed below.


Ingredient matches for Ocuson



Betamethasone

Betamethasone is reported as an ingredient of Ocuson in the following countries:


  • Indonesia

Dexchlorpheniramine

Dexchlorpheniramine maleate (a derivative of Dexchlorpheniramine) is reported as an ingredient of Ocuson in the following countries:


  • Indonesia

International Drug Name Search

Sunday, August 9, 2009

Pulmicort Turbuhaler Orifarm




Pulmicort Turbuhaler Orifarm may be available in the countries listed below.


Ingredient matches for Pulmicort Turbuhaler Orifarm



Budesonide

Budesonide is reported as an ingredient of Pulmicort Turbuhaler Orifarm in the following countries:


  • Denmark

International Drug Name Search

Monday, August 3, 2009

Plivit C




Plivit C may be available in the countries listed below.


Ingredient matches for Plivit C



Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Plivit C in the following countries:


  • Bosnia & Herzegowina

  • Croatia (Hrvatska)

  • Slovenia

International Drug Name Search

Sunday, July 26, 2009

Panaldine




Panaldine may be available in the countries listed below.


Ingredient matches for Panaldine



Ticlopidine

Ticlopidine hydrochloride (a derivative of Ticlopidine) is reported as an ingredient of Panaldine in the following countries:


  • Japan

  • Taiwan

International Drug Name Search

Wednesday, July 15, 2009

Yakuzol




Yakuzol may be available in the countries listed below.


Ingredient matches for Yakuzol



Benzalkonium Chloride

Benzalkonium chloride (a derivative of Benzalkonium) is reported as an ingredient of Yakuzol in the following countries:


  • Japan

International Drug Name Search

Tuesday, July 14, 2009

Carbon Medical




Carbon Medical may be available in the countries listed below.


Ingredient matches for Carbon Medical



Charcoal

Charcoal, Activated is reported as an ingredient of Carbon Medical in the following countries:


  • Argentina

International Drug Name Search

Sunday, July 12, 2009

Tolazamide




In the US, Tolazamide (tolazamide systemic) is a member of the drug class sulfonylureas and is used to treat Diabetes, Type 2.

US matches:

  • Tolazamide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10BB05

CAS registry number (Chemical Abstracts Service)

0001156-19-0

Chemical Formula

C14-H21-N3-O3-S

Molecular Weight

311

Therapeutic Category

Oral antidiabetic agent, sulfonylurea

Chemical Name

Benzenesulfonamide, N-[[(hexahydro-1H-azepin-1-yl)amino]carbonyl]-4-methyl-

Foreign Names

  • Tolazamidum (Latin)
  • Tolazamid (German)
  • Tolazamide (French)
  • Tolazamida (Spanish)

Generic Names

  • Tolazamide (OS: USAN, JAN, DCIT, DCF, BAN)
  • U 17835 (IS)
  • Tolazamide (PH: JP XIV, USP 32, BP 2010)

Brand Names

  • Esulin
    Chung Mei, Taiwan


  • Tolazamide
    Mylan, United States; Sandoz, United States; Watson, United States

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, July 10, 2009

ofloxacin otic



Generic Name: ofloxacin otic (oh FLOCKS a sin OH tic)

Brand names: Floxin Otic, Floxin Otic Singles


What is ofloxacin otic?

Ofloxacin is a fluoroquinolone antibiotic. Ofloxacin fights bacteria in the body.


Ofloxacin is used to treat ear infections.


Ofloxacin otic may also be used for purposes other than those listed in this medication guide.


What is the most important information I should know about ofloxacin otic?


Do not use this medication in the eyes or take it by mouth. Ofloxacin otic is intended for use in the ears only. Do not touch the dropper opening to any surface, including the ears or hands. The dropper opening is sterile. If it becomes contaminated, it could cause another infection in the ear.

Notify your doctor if the condition does not improve or appears to worsen.


What should I discuss with my healthcare provider before using ofloxacin otic?


Do not use ofloxacin otic without first talking to your doctor if you have had a previous allergic reaction to it or to another similar oral or topical fluoroquinolone antibiotic such as:

  • ciprofloxacin (Cipro, CiproDex, Cipro HC), gatifloxacin (Tequin), levofloxacin (Levaquin), lomefloxacin (Maxaquin), moxifloxacin (Avelox), norfloxacin (Noroxin), ofloxacin (Floxin), sparfloxacin (Zagam), or trovafloxacin (Trovan).



You may not be able to use ofloxacin otic, or you may require a dosage adjustment or special monitoring during treatment.


Ofloxacin otic is in the FDA pregnancy category C. This means that it is not known whether it will be harmful to an unborn baby. Do not use ofloxacin otic without first talking to your doctor if you are pregnant or could become pregnant during treatment. It is not known whether ofloxacin otic passes into breast milk. Do not use ofloxacin otic without first talking to your doctor if you are breast-feeding a baby.

How should I use ofloxacin otic?


Use ofloxacin otic exactly as directed by your doctor. If you do not understand these instructions, ask your pharmacist, nurse, or doctor to explain them to you. Do not use this medication in the eyes or take it by mouth. Ofloxacin otic is intended for use in the ears only.

In general, ofloxacin otic should be used as follows:



  • Warm the drops slightly by holding the bottle in the hands for 1 or 2 minutes. Administration of cold drops into the ear may cause dizziness.




  • Have another person administer the drops whenever possible. Have the affected person lie on their side or tilt the ear up to make administering a drop easier.



  • Gently shake the drops just before administration.


  • For adults, gently hold the earlobe up and back. For children, gently hold the earlobe down and back. This will allow the drops to run into the ear canal. Carefully instill the prescribed number of drops in the first ear.




  • Keep the ear tilted for at least 5 minutes to allow the medication to penetrate the ear.




  • If the patient being treated has ear tubes, the doctor may recommend gently pressing the tragus (part of the ear in front of the opening of the ear canal) four to five times in a pumping motion after administration of the drops. This may allow the drops to pass through the tubes into the middle ear. Follow the doctor's instructions.




  • Repeat the process in the other ear if prescribed.



Ofloxacin ear drops are usually used twice a day, about 12 hours apart. Follow your doctor's instructions.


Use all of the medication that has been prescribed. Symptoms may begin to improve before the condition is completely treated. If you do not use all of the medication prescribed, the condition could return or worsen.


It is important to use ofloxacin otic regularly to get the most benefit.


Notify your doctor if the condition does not improve or appears to worsen.


Avoid getting water inside of the affected ear(s) during treatment with ofloxacin. Care should be used while bathing, and swimming may not be recommended. Talk to your healthcare provider.

Store ofloxacin otic at room temperature, away from moisture, heat, and direct light. Keep the bottle properly capped.


What happens if I miss a dose?


Use the missed dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and use only the next regularly scheduled dose. Do not use a double dose of ofloxacin otic unless otherwise directed by your doctor.


What happens if I overdose?


Seek emergency medical attention if an overdose is suspected or if the medication has been ingested.

Symptoms of a ofloxacin otic overdose are not known.


What should I avoid while using ofloxacin?


Ear infections may sometimes cause dizziness or a loss of balance. Use caution when driving, operating machinery, or performing other hazardous activities if you experience dizziness or a loss of balance. Avoid getting water inside of the affected ear(s) during treatment with ofloxacin. Care should be used while bathing, and swimming may not be recommended. Talk to your healthcare provider.

Ofloxacin otic side effects


Stop using ofloxacin otic and seek emergency medical attention or contact your doctor if you experience:

  • an allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);




  • skin rash; or




  • ear drainage, discharge, or worsening pain.



Other less serious side effects may also occur such as ear discomfort or itching, and headache. Continue to use the medication and talk to your doctor if these side effects seem excessive or unusual.


Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.


Ofloxacin otic Dosing Information


Usual Adult Dose for Acute Otitis Externa:

Instill 10 drops into the affected ear(s) once daily for 7 days.

Before administration, the solution should be warmed by holding the bottle in the hand for 1 to 2 minutes. The drops should be instilled with the patient lying on his/her side with the affected ear upward. The patient should stay on his/her side for 5 minutes. Repeat for the opposite ear, if necessary.

Usual Adult Dose for Otitis Media:

Chronic suppurative otitis media with perforated tympanic membrane:
Instill 10 drops into the affected ear(s) twice daily for 14 days.

Before administration, the solution should be warmed by holding the bottle in the hand for 1 to 2 minutes. The drops should be instilled with the patient lying on his/her side with the affected ear upward. After administration, the tragus should be gently pressed 4 times to allow the solution to flow through the tympanic membrane into the middle ear. The patient should stay on his/her side for 5 minutes. Repeat for the opposite ear, if necessary.

Usual Pediatric Dose for Acute Otitis Externa:

6 months to 12 years: Instill 5 drops into the affected ear(s) once daily for 7 days.
>=13 years: Instill 10 drops into the affected ear(s) once daily for 7 days.

Before administration, the solution should be warmed by holding the bottle in the hand for 1 to 2 minutes. The drops should be instilled with the patient lying on his/her side with the affected ear upward. The patient should stay on his/her side for 5 minutes. Repeat for the opposite ear, if necessary.

Usual Pediatric Dose for Otitis Media:

Acute otitis media in patients with tympanostomy tubes:
1 to 12 years: Instill 5 drops into the affected ear(s) twice daily for 10 days.

Chronic suppurative otitis media with perforated tympanic membranes:
>12 years: Instill 10 drops into the affected ear(s) twice daily for 14 days.

Before administration, the solution should be warmed by holding the bottle in the hand for 1 to 2 minutes. The drops should be instilled with the patient lying on his/her side with the affected ear upward. After administration, the outer ear should be gently pulled upward and backward to allow the solution to flow down into the ear canal. The patient should stay on his/her side for 5 minutes. Repeat for the opposite ear, if necessary.


What other drugs will affect my ofloxacin otic?


Do not use other ear drops during treatment with ofloxacin otic without first talking to your doctor.

Drugs other than those listed here may also interact with ofloxacin otic. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines, including vitamins, minerals, and herbal products.



More ofloxacin otic resources


  • Ofloxacin otic Dosage
  • Ofloxacin otic Use in Pregnancy & Breastfeeding
  • Ofloxacin otic Support Group
  • 0 Reviews for Ofloxacin - Add your own review/rating


  • Floxin Otic Solution MedFacts Consumer Leaflet (Wolters Kluwer)

  • Floxin Otic Consumer Overview



Compare ofloxacin otic with other medications


  • Acute Otitis Externa
  • Otitis Media


Where can I get more information?


  • Your pharmacist has more information about ofloxacin otic written for health professionals that you may read.


Thursday, July 9, 2009

Orapred


Generic Name: prednisolone (Oral route)

pred-NIS-oh-lone

Commonly used brand name(s)

In the U.S.


  • Bubbli-Pred

  • Cotolone

  • Flo-Pred

  • Millipred

  • Millipred DP

  • Orapred

  • Orapred ODT

  • Pediapred

  • Prelone

  • Veripred 20

In Canada


  • Pms-Prednisolone

Available Dosage Forms:


  • Solution

  • Tablet

  • Syrup

  • Suspension

  • Liquid

  • Tablet, Disintegrating

Therapeutic Class: Endocrine-Metabolic Agent


Pharmacologic Class: Adrenal Glucocorticoid


Uses For Orapred


Prednisolone provides relief for inflamed areas of the body. It is used to treat a number of different conditions, such as inflammation (swelling), severe allergies, adrenal problems, arthritis, asthma, blood or bone marrow problems, eye or vision problems, lupus, skin conditions, kidney problems, ulcerative colitis, and flare-ups of multiple sclerosis. Prednisolone is a corticosteroid (cortisone-like medicine or steroid). It works on the immune system to help relieve swelling, redness, itching, and allergic reactions.


This medicine is available only with your doctor's prescription.


Before Using Orapred


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of prednisolone in children. However, pediatric patients are more likely to have slower growth and bone problems if prednisolone is used for a long time. Recommended doses should not be exceeded, and the patient should be carefully monitored during therapy.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of prednisolone in the elderly. However, elderly patients are more likely to have age-related kidney and bone problems, which may require caution and an adjustment in the dose for elderly patients receiving prednisolone.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Rotavirus Vaccine, Live

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Aldesleukin

  • Asparaginase

  • Bupropion

  • Quetiapine

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Alatrofloxacin

  • Alcuronium

  • Amobarbital

  • Aspirin

  • Atracurium

  • Balofloxacin

  • Cinoxacin

  • Ciprofloxacin

  • Clinafloxacin

  • Desogestrel

  • Dienogest

  • Drospirenone

  • Enoxacin

  • Estradiol Cypionate

  • Estradiol Valerate

  • Ethinyl Estradiol

  • Ethynodiol Diacetate

  • Etonogestrel

  • Fleroxacin

  • Flumequine

  • Fosphenytoin

  • Gallamine

  • Gemifloxacin

  • Grepafloxacin

  • Hexafluorenium

  • Itraconazole

  • Levofloxacin

  • Levonorgestrel

  • Licorice

  • Lomefloxacin

  • Medroxyprogesterone Acetate

  • Mestranol

  • Metocurine

  • Moxifloxacin

  • Norelgestromin

  • Norethindrone

  • Norfloxacin

  • Norgestimate

  • Norgestrel

  • Ofloxacin

  • Pefloxacin

  • Phenytoin

  • Primidone

  • Prulifloxacin

  • Rifampin

  • Rosoxacin

  • Rufloxacin

  • Saiboku-To

  • Sparfloxacin

  • Temafloxacin

  • Tosufloxacin

  • Trovafloxacin Mesylate

  • Vecuronium

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Cataracts or

  • Congestive heart failure or

  • Cushing's syndrome (adrenal gland problem) or

  • Diabetes or

  • Eye infection or

  • Glaucoma or

  • Hyperglycemia (high blood sugar) or

  • Hypertension (high blood pressure) or

  • Infection (e.g., bacterial, virus, or fungus) or

  • Mood changes, including depression or

  • Myasthenia gravis (severe muscle weakness) or

  • Osteoporosis (weak bones) or

  • Peptic ulcer, active or history of or

  • Personality changes or

  • Stomach or intestinal problems (e.g., diverticulitis, ulcerative colitis) or

  • Tuberculosis, inactive—Use with caution. May make these conditions worse.

  • Fungal infections or

  • Herpes simplex eye infection—Should not be used in patients with these conditions.

  • Kidney disease—Use with caution. The effects may be increased because of slower removal of the medicine from the body.

Proper Use of prednisolone

This section provides information on the proper use of a number of products that contain prednisolone. It may not be specific to Orapred. Please read with care.


Take this medicine exactly as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered. To do so may increase the chance for unwanted effects.


This medicine comes with a patient instruction insert. Read and follow the instructions in the insert carefully. Ask your doctor if you have any questions.


This medicine should be taken with food to avoid stomach irritation.


Measure the oral liquid with the special oral syringe that comes with the package. The average household teaspoon may not hold the right amount of liquid.


If you use this medicine for a long time, do not suddenly stop using it without checking first with your doctor. You may need to slowly decrease your dose before stopping it completely.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (solution, suspension, syrup, tablets):
    • Dose depends on medical condition:
      • Adults—At first, 5 to 60 milligrams (mg) per day. Your doctor may adjust your dose as needed.

      • Children—Dose is based on body weight and must be determined by your doctor. The dose is usually 0.14 to 2 mg per kilogram (kg) of body weight per day, divided and taken 3 or 4 times a day. Your doctor may adjust your dose as needed.



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using Orapred


If you will be taking this medicine for a long time, it is very important that your doctor check you at regular visits for any unwanted effects that may be caused by this medicine. Blood or urine tests may be needed to check for unwanted effects.


Using this medicine while you are pregnant can harm your unborn baby. Use an effective form of birth control to keep from getting pregnant. If you think you have become pregnant while using this medicine, tell your doctor right away.


Using too much of this medicine or using it for a long time may increase your risk of having adrenal gland problems. Talk to your doctor right away if you have more than one of these symptoms while you are using this medicine: blurred vision; dizziness or fainting; a fast, irregular, or pounding heartbeat; increased thirst or urination; irritability; or unusual tiredness or weakness.


This medicine may cause you to get more infections than usual. Avoid people who are sick or have infections and wash your hands often. If you are exposed to chickenpox or measles, tell your doctor right away. If you start to have a fever, chills, sore throat, or any other sign of an infection, call your doctor right away.


This medicine may cause changes in mood or behavior for some patients. Tell your doctor right away if you have depression; mood swings; a false or unusual sense of well-being; trouble with sleeping; or personality changes while taking this medicine.


This medicine might cause thinning of the bones (osteoporosis) or slow growth in children if used for a long time. Tell your doctor if you have any bone pain or if you have an increased risk for osteoporosis. If your child is using this medicine, tell the doctor if you think your child is not growing properly.


If you are using this medicine for a long time, tell your doctor about any extra stress or anxiety in your life, including other health concerns and emotional stress. Your dose of this medicine might need to be changed for a short time while you have extra stress.


Check with your doctor right away if blurred vision, difficulty in reading, or any other change in vision occurs during or after treatment. Your doctor may want you to have your eyes checked by an ophthalmologist (eye doctor).


While you are being treated with prednisolone, do not have any immunizations (vaccines) without your doctor's approval. Prednisolone may lower your body's resistance and the vaccine may not work as well or you might get the infection the vaccine is meant to prevent. In addition, you should not be around other persons living in your household who receive live virus vaccines because there is a chance they could pass the virus on to you. Some examples of live vaccines include measles, mumps, influenza (nasal flu vaccine), poliovirus (oral form), rotavirus, and rubella. Do not get close to them and do not stay in the same room with them for very long. If you have questions about this, talk to your doctor.


Make sure any doctor or dentist who treats you knows that you are using this medicine. This medicine may affect the results of certain skin tests.


Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.


Orapred Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Aggression

  • agitation

  • anxiety

  • blurred vision

  • decrease in the amount of urine

  • dizziness

  • fast, slow, pounding, or irregular heartbeat or pulse

  • headache

  • irritability

  • mental depression

  • mood changes

  • nervousness

  • noisy, rattling breathing

  • numbness or tingling in the arms or legs

  • pounding in the ears

  • shortness of breath

  • swelling of the fingers, hands, feet, or lower legs

  • trouble thinking, speaking, or walking

  • troubled breathing at rest

  • weight gain

Incidence not known
  • Abdominal cramping and/or burning (severe)

  • abdominal pain

  • backache

  • bloody, black, or tarry stools

  • cough or hoarseness

  • darkening of skin

  • decrease in height

  • decreased vision

  • diarrhea

  • dry mouth

  • eye pain

  • eye tearing

  • facial hair growth in females

  • fainting

  • fatigue

  • fever or chills

  • flushed, dry skin

  • fractures

  • fruit-like breath odor

  • full or round face, neck, or trunk

  • heartburn and/or indigestion (severe and continuous)

  • increased hunger

  • increased thirst

  • increased urination

  • loss of appetite

  • loss of sexual desire or ability

  • lower back or side pain

  • menstrual irregularities

  • muscle pain or tenderness

  • muscle wasting or weakness

  • nausea

  • pain in back, ribs, arms, or legs

  • painful or difficult urination

  • skin rash

  • sleeplessness

  • sweating

  • trouble healing

  • trouble sleeping

  • unexplained weight loss

  • unusual tiredness or weakness

  • vision changes

  • vomiting

  • vomiting of material that looks like coffee grounds

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Increased appetite

Incidence not known
  • Abnormal fat deposits on the face, neck, and trunk

  • acne

  • dry scalp

  • lightening of normal skin color

  • red face

  • reddish purple lines on the arms, face, legs, trunk, or groin

  • swelling of the stomach area

  • thinning of the scalp hair

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.